Biological Evaluation of Pupalia lappacea for Antidiabetic, Antiadipogenic, and Hypolipidemic Activity Both In Vitro and In Vivo
Objective. The present study assesses the effect of Pupalia lappacea (L.) Juss. (Amaranthaceae) (PL) leaves ethanolic extract on adipocytes, blood glucose level, and lipid level in streptozotocin (STZ) induced diabetic rats. Materials and Methods. Male Albino rats were rendered diabetic by a single...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Scientifica |
| Online Access: | http://dx.doi.org/10.1155/2016/1062430 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558310874677248 |
|---|---|
| author | Vivek Kumar Parag Jain Kalpana Rathore Zabeer Ahmed |
| author_facet | Vivek Kumar Parag Jain Kalpana Rathore Zabeer Ahmed |
| author_sort | Vivek Kumar |
| collection | DOAJ |
| description | Objective. The present study assesses the effect of Pupalia lappacea (L.) Juss. (Amaranthaceae) (PL) leaves ethanolic extract on adipocytes, blood glucose level, and lipid level in streptozotocin (STZ) induced diabetic rats. Materials and Methods. Male Albino rats were rendered diabetic by a single moderately sized dose of STZ (45 mg/kg, intraperitoneally) at once before starting the treatment. Animals were divided into five groups: normoglycemic control, diabetic control, reference group (glibenclamide, 5.0 mg/kg), AS001 (250 mg/kg extract), and AS002 (500 mg/kg extract) each containing six animals for in vivo study. Antidiabetic and hypolipidemic activity of extract were determined by in vivo method on STZ induced diabetic rats. Antiadipogenic activity was determined by in vitro method on 3T3-L1 cell line in comparison to simvastatin as reference drug. Result. The extract showed significant fall in fasting serum glucose (FSG), that is, 234.68 and 211.61 mg/dL, in STZ induced diabetic animals for dose groups AS001 and AS002, respectively. The PL extract also exhibited noteworthy antiadipogenic activity on 3T3-L1 cell line. The value of inhibitory concentration (IC50) of PL extract to reduce adipocyte cells was found to be 662.14 μg/mL. Conclusion. The PL extract exhibited significant antiadipogenic, antidiabetic, and hypolipidemic activities. |
| format | Article |
| id | doaj-art-44d888fcb3a247ed9b96159ac003abec |
| institution | Kabale University |
| issn | 2090-908X |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Scientifica |
| spelling | doaj-art-44d888fcb3a247ed9b96159ac003abec2025-02-03T01:32:46ZengWileyScientifica2090-908X2016-01-01201610.1155/2016/10624301062430Biological Evaluation of Pupalia lappacea for Antidiabetic, Antiadipogenic, and Hypolipidemic Activity Both In Vitro and In VivoVivek Kumar0Parag Jain1Kalpana Rathore2Zabeer Ahmed3Department of Pharmacology, School of Pharmacy, Babu Banarasi Das University, Lucknow, Uttar Pradesh 226005, IndiaDepartment of Pharmacology, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya, Bilaspur, Chhattisgarh 495334, IndiaUniversity Teaching Department, Sarguja University, Ambikapur, Chhattisgarh 497001, IndiaDepartment of Pharmacology, Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir 180001, IndiaObjective. The present study assesses the effect of Pupalia lappacea (L.) Juss. (Amaranthaceae) (PL) leaves ethanolic extract on adipocytes, blood glucose level, and lipid level in streptozotocin (STZ) induced diabetic rats. Materials and Methods. Male Albino rats were rendered diabetic by a single moderately sized dose of STZ (45 mg/kg, intraperitoneally) at once before starting the treatment. Animals were divided into five groups: normoglycemic control, diabetic control, reference group (glibenclamide, 5.0 mg/kg), AS001 (250 mg/kg extract), and AS002 (500 mg/kg extract) each containing six animals for in vivo study. Antidiabetic and hypolipidemic activity of extract were determined by in vivo method on STZ induced diabetic rats. Antiadipogenic activity was determined by in vitro method on 3T3-L1 cell line in comparison to simvastatin as reference drug. Result. The extract showed significant fall in fasting serum glucose (FSG), that is, 234.68 and 211.61 mg/dL, in STZ induced diabetic animals for dose groups AS001 and AS002, respectively. The PL extract also exhibited noteworthy antiadipogenic activity on 3T3-L1 cell line. The value of inhibitory concentration (IC50) of PL extract to reduce adipocyte cells was found to be 662.14 μg/mL. Conclusion. The PL extract exhibited significant antiadipogenic, antidiabetic, and hypolipidemic activities.http://dx.doi.org/10.1155/2016/1062430 |
| spellingShingle | Vivek Kumar Parag Jain Kalpana Rathore Zabeer Ahmed Biological Evaluation of Pupalia lappacea for Antidiabetic, Antiadipogenic, and Hypolipidemic Activity Both In Vitro and In Vivo Scientifica |
| title | Biological Evaluation of Pupalia lappacea for Antidiabetic, Antiadipogenic, and Hypolipidemic Activity Both In Vitro and In Vivo |
| title_full | Biological Evaluation of Pupalia lappacea for Antidiabetic, Antiadipogenic, and Hypolipidemic Activity Both In Vitro and In Vivo |
| title_fullStr | Biological Evaluation of Pupalia lappacea for Antidiabetic, Antiadipogenic, and Hypolipidemic Activity Both In Vitro and In Vivo |
| title_full_unstemmed | Biological Evaluation of Pupalia lappacea for Antidiabetic, Antiadipogenic, and Hypolipidemic Activity Both In Vitro and In Vivo |
| title_short | Biological Evaluation of Pupalia lappacea for Antidiabetic, Antiadipogenic, and Hypolipidemic Activity Both In Vitro and In Vivo |
| title_sort | biological evaluation of pupalia lappacea for antidiabetic antiadipogenic and hypolipidemic activity both in vitro and in vivo |
| url | http://dx.doi.org/10.1155/2016/1062430 |
| work_keys_str_mv | AT vivekkumar biologicalevaluationofpupalialappaceaforantidiabeticantiadipogenicandhypolipidemicactivitybothinvitroandinvivo AT paragjain biologicalevaluationofpupalialappaceaforantidiabeticantiadipogenicandhypolipidemicactivitybothinvitroandinvivo AT kalpanarathore biologicalevaluationofpupalialappaceaforantidiabeticantiadipogenicandhypolipidemicactivitybothinvitroandinvivo AT zabeerahmed biologicalevaluationofpupalialappaceaforantidiabeticantiadipogenicandhypolipidemicactivitybothinvitroandinvivo |